Andrew Norato
Physician Assistant · Philadelphia, PANPI 1023655628
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by AstraZeneca at 25.5% of the total. 2025 is the largest year on record at $2,014, 3.3 times the $607 reported in 2021. Among physician assistant clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $32.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$771
- Lilly USA, LLC$740
- Bayer$556
- AbbVie$501
- Boehringer Ingelheim$304
- plus $2K from 29 others
What the payments were for
- Food & beverage$7,111100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $1,816 |
| Novo Nordisk | 31 | $771 |
| Lilly USA, LLC | 32 | $740 |
| Bayer | 19 | $556 |
| AbbVie(2 entities) | 16 | $501 |
| Boehringer Ingelheim | 5 | $304 |
| Amgen(2 entities) | 13 | $294 |
| Dexcom, Inc. | 5 | $229 |
| GSK | 10 | $166 |
| Genentech USA, Inc. | 2 | $164 |
| Johnson & Johnson | 8 | $157 |
| Otsuka America Pharmaceutical, Inc. | 4 | $148 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $136 |
| Axsome Therapeutics, Inc. | 3 | $135 |
| Pfizer | 6 | $134 |
| Exact Sciences | 7 | $130 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $125 |
| Sanofi | 1 | $122 |
| Globus Medical | 2 | $75 |
| Phathom Pharmaceuticals, Inc. | 2 | $59 |
| Nevro Corp. | 3 | $50 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| Edwards Lifesciences | 1 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Photonicare Inc | 1 | $27 |
| Phadia US Inc. | 1 | $23 |
| Servier Pharmaceuticals LLC | 1 | $22 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| 180 Medical, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$849
- JARDIANCE$366
- BREZTRI$363
- Kerendia$260
- DUPIXENT$244
- AIRSUPRA$237
- TECENTRIQ$143
- DEXCOM G7 GSS (161)$142
- Wegovy$125
- ZEPBOUND$125
- IMBRUVICA$125
- VRAYLAR$124
- Auvelity$123
- EVENITY$123
- RYBELSUS$121
- Ozempic$121
- NURTEC ODT$120
- ABILIFY MAINTENA$117
- ABILIFY ASIMTUFII$117
- QULIPTA$115
How this compares
$7,111 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 30 | $34,758 |
| TrulicityDulaglutide | 19 | $21,085 |
| FarxigaDapagliflozin Propanediol | 19 | $18,134 |
| JardianceEmpagliflozin | 17 | $10,210 |
| Gabapentin | 60 | $839 |
| Levothyroxine Sodium | 86 | $799 |
| Rosuvastatin Calcium | 62 | $680 |
| Omeprazole | 32 | $473 |
| Baclofen | 25 | $445 |
| Telmisartan | 30 | $441 |
| Atorvastatin Calcium | 68 | $435 |
| Amlodipine Besylate | 69 | $368 |
| Azelastine Hcl | 12 | $367 |
| Metoprolol Succinate | 43 | $335 |
| Valsartan | 30 | $303 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $771 | $34,75830 claims |
| Lilly USA, LLCTrulicity | $740 | $21,08519 claims |
| AstraZenecaFarxiga | $1,816 | $18,13419 claims |
| Boehringer IngelheimJardiance | $304 | $10,21017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Philadelphia
- Melissa FerrariPhiladelphia$223K
- Alvin KingcadePhiladelphia$68K
- Trevor BonneyPhiladelphia$44K
- Ashwin GuptaPhiladelphia$33K
- Christopher EsworthyPhiladelphia$31K
- Carolyn ZawislakPhiladelphia$29K
- Kristen JonesPhiladelphia$22K
- Simone HoldenPhiladelphia$17K
- Erin CrownState College$1.2M
- Tricia BootsCranberry Twp$313K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.